Medidata, a Dassault Systèmes brand and a leading provider of clinical trial solutions for the life sciences industry, announced an extension of its strategic partnership with Sanofi. Under the renewed agreement, Sanofi will adopt Medidata's Patient, Data, and Study Experiences to further its mission of accelerating innovation in clinical studies, bringing new therapies to market faster, and improving global health outcomes.
The Medidata Experiences offer AI-driven, platform-based solutions that streamline clinical workflows, replacing fragmented and standalone tools commonly used in the industry. By integrating these capabilities with Sanofi's pharmaceutical expertise, the collaboration aims to enhance the precision and impact of clinical trials while reducing operational silos, costs, and delays.
As part of the expanded partnership, Sanofi will leverage Medidata's leadership in decentralized clinical trials. Medidata will provide comprehensive consulting and end-to-end operational support to help execute more agile and patient-centric studies.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.